Sunday 18 October 2026
Export PLRZ’s income statement to Excel — free account
Polyrizon Ltd.
PLRZ Healthcare Biotechnology
10.00
0.01
−0.10%
Follow PLRZ
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
Current Ratio |
29.03 | 10.16 | 0.11 | 0.04 |
Net Debt/EBITDA |
2.11 | 2.16 | (0.25) | 0.04 |
Debt/Assets |
0.00% | 0.00% | 35.78% | 0.00% |
Debt/Equity |
0.00 | 0.00 | (1.05) | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
1.36 | 0.74 | 0.90 | 1.45 |
Capex/Depreciation |
(0.02) | 0.00 | 0.00 | (0.60) |
| (25.38%) | (60.65%) | 109.99% | 0.00% | |
| (24.72%) | (50.61%) | (108.60%) | 0.00% | |
ROIC |
(45.79%) | (29.79%) | 0.00% | 0.00% |
Return on Tangible Assets |
(26.83%) | (64.32%) | 137.61% | 68.88% |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.12 | 0.52 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(6.67) | (573.50) | (383.57) | (1,261.11) |
Cash per Share |
18.32 | 1,277.00 | 29.29 | 40.00 |
Shareholders Equity per Share |
30.86 | 2,643.00 | (136.43) | (1,000.00) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
30.86 | 2,643.00 | (136.43) | (1,000.00) |
Free Cash Flow |
(4.53) | (1.15) | (0.54) | (1.13) |
Working Capital |
12.42 | 2.39 | (0.45) | (1.15) |
Capital Expenditures |
(0.01) | — | — | 0.00 |
Net Current Asset Value |
12.42 | 2.39 | (0.70) | (1.39) |
| Other line items | ||||
Quick Ratio |
28.14 | 9.79 | 0.08 | 0.03 |
Depreciation/Fixed assets |
28.50 | 11.80 | 0.33 | 0.31 |
Cash ROIC |
(13.55%) | (14.63%) | (1,074.00%) | 131.37% |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(6.65) | (573.50) | (383.57) | (1,257.78) |
Capex per Share |
(0.01) | 0.00 | 0.00 | (3.33) |
Average Assets |
13.49 | 3.05 | 0.55 | — |
Average Common Equity |
13.14 | 2.55 | (0.55) | — |
Capex to Sales |
0.00 | — | — | 0.00 |
Columns are period end dates · fundamentals updated 30 Sep 2026